This is an old revision of this page, as edited by Dcirovic (talk | contribs) at 14:36, 29 May 2012 (→References). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:36, 29 May 2012 by Dcirovic (talk | contribs) (→References)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Identifiers | |
|---|---|
IUPAC name
| |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H19N3O3 |
| Molar mass | 337.372 g/mol g·mol |
| 3D model (JSmol) | |
SMILES
| |
| (verify) | |
MMPIP is a drug used in scientific research that acts as a selective antagonist for the metabotropic glutamate receptor subtype mGluR7. This receptor subtype appears to be involved in the downstream response to cocaine in the brain.
References
- Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H, Mitsuya M, Ohkubo M, Ohta H (2007). "In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists". The Journal of Pharmacology and Experimental Therapeutics. 323 (1): 147–56. doi:10.1124/jpet.107.124701. PMID 17609420.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - Li X, Li J, Peng XQ, Spiller K, Gardner EL, Xi ZX (2009). "Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism". Neuropsychopharmacology. 34 (7): 1783–96. doi:10.1038/npp.2008.236. PMID 19158667.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
 | This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |